| Literature DB >> 31370778 |
Binbin Wen1,2, Wenliang Song1,2, Mingyue Sun1,2, Min Chen1,2, Qin Mu1, Xinhao Zhang1,2, Qijie Wu1, Xiude Chen1,2,3, Dongsheng Gao4,5,6, Hongyu Wu7,8,9.
Abstract
BACKGROUND: Fruit set after successful pollination is key for the production of sweet cherries, and a low fruit-setting rate is the main problem in production of this crop. As gibberellin treatment can directly induce parthenogenesis and satisfy the hormone requirement during fruit growth and development, such treatment is an important strategy for improving the fruit-setting rate of sweet cherries. Previous studies have mainly focused on physiological aspects, such as fruit quality, fruit size, and anatomical structure, whereas the molecular mechanism remains clear. <br> RESULTS: In this study, we analyzed the transcriptome of 'Meizao' sweet cherry fruit treated with gibberellin during the anthesis and hard-core periods to identify genes associated with parthenocarpic fruit set. A total of 25,341 genes were identified at the anthesis and hard-core stages, 765 (681 upregulated, 84 downregulated) and 186 (141 upregulated, 45 downregulated) of which were significant differentially expressed genes (DEGs) at the anthesis and the hard-core stages after gibberellin 3 (GA3) treatment, respectively. Based on DEGs between the control and GA3 treatments, the GA3 response mainly involves parthenocarpic fruit set and cell division. Exogenous gibberellin stimulated sweet cherry fruit parthenocarpy and enlargement, as verified by qRT-PCR results of related genes as well as the parthenocarpic fruit set and fruit size. Based on our research and previous studies in Arabidopsis thaliana, we identified key genes associated with parthenocarpic fruit set and cell division. Interestingly, we observed patterns among sweet cherry fruit setting-related DEGs, especially those associated with hormone balance, cytoskeleton formation and cell wall modification. <br> CONCLUSIONS: Overall, the result provides a possible molecular mechanism regulating parthenocarpic fruit set that will be important for basic research and industrial development of sweet cherries.Entities:
Keywords: Fruit set and cell division; GA3; Parthenocarpy; Sweet cherry; Transcriptome
Mesh:
Substances:
Year: 2019 PMID: 31370778 PMCID: PMC6670208 DOI: 10.1186/s12863-019-0746-8
Source DB: PubMed Journal: BMC Genet ISSN: 1471-2156 Impact factor: 2.797
The size of GA3-treated sweet cherry
| Treatment | 7 DAT | 17 DAT | 27 DAT | 37 DAT | 47 DAT | |
|---|---|---|---|---|---|---|
| Transverse diameter/mm | CK1 | 3.577b ± 0.872 | 10.437a ± 1.766 | |||
| T1 | 8.01e ± 1.009 | 10.488d ± 0.613 | 14.268c ± 0.922 | 17.895 ± 1.053 | 27.698a ± 1.328 | |
| Growth rate/% | 123.9 | 0.49 | ||||
| vertical diameter/mm | CK2 | 3.577b ± 0.872 | 10.437a ± 1.766 | |||
| T2 | 11.235e ± 1.287 | 14.002d ± 0.805 | 17.359c ± 0.913 | 18.83b ± 1.165 | 25.434 ± 1.984 | |
| Growth rate/% | 214.09 | 34.16 |
Different lowercase letters indicate significant differences between the different treatments at the p < 0.05 level
CK Control groups without GA3 treatment
T GA3 treatment groups
DAT Days after treatment
Growth rate (GA3 treatment–control)/control× 100%
Fig. 1Growth curves of sweet cherry fruits in the treatment and control groups, respectively. T, transverse diameter; V, vertical diameter
Fig. 2Effect of GA3 treatment on fruit shape, fruit-setting rate and parthenogenetic rate of sweet cherry. a Treatment: 7 days after treatment (7 DAT); b 17 DAT; c 27 DAT; d 37 DAT; e 47 DAT; f Control: 7 days after full bloom; g 17 days after full bloom; h Fruit-setting rate; i Parthenogenetic rate
Quality control of the clean data
| Sample | Raw of Number | Clean read% | Remove Adapter % | Ns Reads Rate % | Low quality % | Clean Q30 Bases Rate (%) | Mapping Rate % | Exon % | Intron % | Intergenic % |
|---|---|---|---|---|---|---|---|---|---|---|
| CK11 | 45,723,590 | 99.27 | 0.7 | 0.02 | 0 | 92.87 | 83 | 81.2 | 9.01 | 9.8 |
| CK12 | 45,297,964 | 98.82 | 1.16 | 0.02 | 0 | 92.77 | 80 | 81.51 | 8.38 | 10.12 |
| CK13 | 46,636,712 | 99.25 | 0.73 | 0.02 | 0 | 92.37 | 86 | 82.23 | 8.46 | 9.31 |
| CK21 | 44,993,708 | 99.14 | 0.84 | 0.02 | 0 | 92.39 | 85 | 81.04 | 9.16 | 9.81 |
| CK22 | 44,432,270 | 99.28 | 0.7 | 8.55E–05 | 0.02 | 91.63 | 84 | 80.06 | 10.15 | 9.79 |
| CK23 | 45,263,166 | 99.06 | 0.91 | 0.02 | 0 | 92.17 | 82 | 81.5 | 9.04 | 9.46 |
| T11 | 45,225,288 | 99.07 | 0.91 | 0.02 | 0 | 92.41 | 82 | 81.03 | 9.22 | 9.75 |
| T12 | 47,694,260 | 98.96 | 1.02 | 0.02 | 0 | 92.13 | 86 | 82.08 | 8.45 | 9.47 |
| T13 | 47,760,684 | 99.29 | 0.68 | 0 | 0.03 | 89.68 | 81 | 79.47 | 10.21 | 10.33 |
| T21 | 45,251,876 | 99.11 | 0.87 | 0.02 | 0 | 92.46 | 76 | 81.01 | 9.35 | 9.64 |
| T22 | 47,477,702 | 98.99 | 0.98 | 0.02 | 0 | 92.32 | 83 | 81 | 9.15 | 9.85 |
| T23 | 45,849,530 | 99.21 | 0.77 | 0.02 | 0 | 92.38 | 80 | 81.66 | 8.86 | 9.48 |
The Ns reads rate indicates that N is too high; the number of sequences that have been removed accounts for the proportion of the original sequence number
Intergenic: new transcripts, expression noise, etc., result in sequences derived from intergenic regions
CK1 control groups without GA treatment in the anthesis stage
CK2 control groups without GA treatment in the hard nucleus stage
T1 GA treatment groups in the anthesis stage
T2 GA treatment groups in the hard-nucleus stage
Fig. 3Analysis of DEGs at the two key sweet cherry developmental stages (anthesis and hard-core stages). a Numbers of DEGs between the control and GA3-treated samples at the two developmental stages; b Venn diagram of the up-regulated genes identified at the two sweet cherry development stages
Fig. 4Analysis of DEGs in different transcription factor families. a The dashed line indicates the average number of DEGs for the different transcription factor families; b The proportion of different transcription factor families between the control and treatment groups relative to the total number of transcription factor families
Fig. 5Expression analysis of genes from different transcription factor families (T1/C1)
Fig. 6Expression analysis of genes from different transcription factor families (T2/C2)
Fig. 7KEGG pathway analysis of DEGs at the two different developmental stages of sweet cherry
Fig. 8Gene ontology (GO) (corrected P-value≤0.05) analysis of DEGs between the control and GA3 treatments. a GO analysis of DEGs between the T1/C1 groups; b GO analysis of DEGs between the T2/C2 groups. The Y-axis represents the percentage of annotated DEGs for each GO term relative to the total number of DEGs
Fig. 9Expression pattern based on DEG clustering at the two key sweet cherry developmental stages. DEG clustering was performed using the k-means method. The number behind each cluster name represents the number of different genes in the cluster. The X-axis shows the different samples. The Y-axis shows the log2 RPKM values during the development of sweet cherry. The gray line indicates the gene expression changes between samples. The dark purple line represents the mean gene expression values. The red line indicates that the FPKM value (log2) is 0
Fig. 10Expression analysis of genes participating in three biological processes. a Eight genes related to fruit setting were selected for qRT-PCR analysis; b Twelve genes related to cell division were selected for qRT-PCR analysis; c Ten genes related to parthenocarpy were selected for qRT-PCR analysis; d Coefficient analysis between the qRT-PCR and RNA-seq results
Fig. 11A model for parthenocarpy molecular regulation in sweet cherry. The red and blue frames show the up-regulated and down-regulated genes, respectively. The red and green lines indicate positive and negative regulation, respectively. The dashed line shows hypothetical interactions